US2019167835A1PendingUtilityA1

Antioxidant and antimicrobial wound dressing materials

Assignee: KCI USA INCPriority: Nov 18, 2003Filed: Nov 30, 2018Published: Jun 6, 2019
Est. expiryNov 18, 2023(expired)· nominal 20-yr term from priority
A61P 31/00A61F 13/0206A61F 13/0256A61L 2300/404A61L 15/44A61P 17/02B65B 55/12A61L 15/46A61L 15/325A61F 13/0226A61L 2300/21A61L 15/56A61L 15/64A61F 13/0209A61F 13/0213B65B 5/04A61L 15/28A61L 15/20A61F 13/0203A61L 15/18
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A wound dressing material may include a polymeric substrate, a silver salt, and a dyestuff to photostabilize the silver salt. The substrate may include collagen and/or oxidized regenerated cellulose complexed to Ag+, and the dyestuff may, for example, be an aniline or acridine dye. Also disclosed are methods of making such materials, and wound dressings that include such materials.

Claims

exact text as granted — not AI-modified
1 . A wound dressing material comprising a polymeric substrate, a silver salt, and a dyestuff to photostabilize the silver salt. 
     
     
         2 . A wound dressing material according to  claim 1 , wherein the substrate comprises a solid bioabsorbable material, preferably selected from the group consisting of collagens, oxidized celluloses, chitosans, galactomannans, glycosaminoglycans, and mixtures thereof. 
     
     
         3 . A wound dressing material according to  claim 2 , wherein the substrate comprises a solid bioabsorbable material selected from the group consisting of collagens, oxidized celluloses, chitosans, and mixtures thereof. 
     
     
         4 . A wound dressing material according to  claim 1 , wherein the substrate is selected from the group consisting of celluloses, alginates, polyacrylates, polyurethanes, polyamides, and mixtures thereof. 
     
     
         5 . A wound dressing material according to  claim 1 , wherein the wound dressing material is in the form of a continuous solid sheet, an apertured solid sheet, a web, a woven fabric, a knitted fabric, a nonwoven fabric, a freeze-dried sponge or a solvent-dried sponge. 
     
     
         6 . A wound dressing material according to  claim 1 , wherein the polymeric substrate comprises an anionic polymer, and said silver salt comprises a salt of Ag +  with the anionic polymer. 
     
     
         7 . A wound dressing material according to  claim 1 , wherein the composition comprises from about 0.01 wt. % to about 5 wt. % of silver, based on the dry weight of the composition. 
     
     
         8 . A wound dressing material according to  claim 1 , wherein the dyestuff comprises an antioxidant dyestuff, for example selected from the group consisting of aniline dyes, acridine dyes, thionine dyes, bis-naphthalene dyes, thiazine dyes, azo dyes, anthraquinones, and mixtures thereof. 
     
     
         9 . A wound dressing material according to  claim 8 , wherein the antioxidant dyestuff is selected from the group consisting of gentian violet, aniline blue, methylene blue, crystal violet, acriflavine, 9-aminoacridine, acridine yellow, acridine orange, proflavin, quinacrine, brilliant green, trypan blue, trypan red, malachite green, azacrine, methyl violet, methyl orange, methyl yellow, ethyl violet, acid orange, acid yellow, acid blue, acid red, thioflavin, alphazurine, indigo blue, methylene green, and mixtures thereof. 
     
     
         10 . A wound dressing material according to  claim 1 , wherein the dyestuff is present in an amount of from about 0.2 to about 2 wt. % based on the dry weight of the material. 
     
     
         11 . A wound dressing material according to  claim 1 , wherein the polymeric substrate consists essentially of a mixture of an oxidized cellulose with a collagen and/or a chitosan. 
     
     
         12 . A wound dressing material according to  claim 1 , wherein the material is sterile and packaged in a microorganism-impermeable container. 
     
     
         13 . A wound dressing material according to  claim 1 , wherein the material has a free radical activity in the diphenylpicrylhydrazyl (DPPH) test for antioxidant activity as herein defined of at least about 15%. 
     
     
         14 . A method for treating a wound, the method comprising administering to the wound a wound dressing material of  claim 1 . 
     
     
         15 . The method of  claim 14 , wherein the wound is a chronic wound, preferably selected from the group consisting of ulcers of venous ulcers, decubitus ulcers, or diabetic ulcers. 
     
     
         16 - 19 . (canceled)

Join the waitlist — get patent alerts

Track US2019167835A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.